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動態と血小板機能を観察し，血液流動性との関連を検討した．本実験では 8週齢，約 120g の






































を，Micro Channel array Flow Analyzer（MC-
FAN）assay でヒトあるいはラットを用いて報告し















研 究 方 法
　1．薬剤とその投与
　本実験で使用したDABは SIGMA社（St Louis, 
MO, USA）から購入したものである．Fig. 1 に示
したように，被験ラットにはDABを 0.06％の割合
で餌（CE-210，日本クレア（株））に混合した特殊






ての動物を実験開始後 18 週目（26 週齢）で実験に
使用した．
　2．実験動物























EDTA-2K を用い，血液 1 ml への添加濃度はそれ
ぞれ 45 単位，1，6％，1.2 mg であった9）．
　5．血漿の採取
　クエン酸ナトリウムで凝固を阻止した血液 2 ml
を 400×gで 5 分間の遠心後，得られた上清を多血
小板血漿（platelet-rich plasma : PRP）とした．PRP
を採取した残りの血液を再び 2,300×gで 5分間遠心



















に調整 PRP を 270μl 取り，37℃で予備加熱後，ア
ゴニストとしてアデノシン二リン酸（ADP;  
Oriental Yeast Co., Ltd.）を生理食塩水で 100μM
Fig. 1　Experimental procedure
The EH group was administered DAB mixing diet 
for 16 weeks and changed to regular diet for two 
weeks before dissection.
The all animals were anatomized in 26 weeks old. 
（each group : n＝5）
安　 齋 　　勉・ほか
604









array Flow Analyzer KH-6（MC-FAN; エムシー研
究所（株））を用いて測定した．この際使用したマ
イクロチャネルアレイはBloody7-7（幅（呼び径）6.4
±0.5μm，流路数 7,854 本，長さ 30±5μm，深さ
4.5±0.5μm）であった．ヘパリンナトリウムおよ







元配置の分散分析ならびに post-hoc test として











































































Control group 55.84±1.35 40.00±1.48 829.2±5.01 42.42±0.69 314.00±11.11
EH group 50.54±2.25＊ 40.00±1.79 831.0±8.98 42.72±1.13 284.00±6.96
Asterisk shows statistically signiﬁcant diﬀerence as compared with the control （P＜0.05）. （each group : n
＝5, mean±SE）
Fig. 2　Autopsy ﬁnding of the liver
These are hepatic appearance photographs of rats in 26 weeks old.
The arrows are degenerative parts.
Fig. 3　Histological ﬁndings （Hematoxylin Eosin stain）
“A and a” are control group, “B and b” are EH group （DAB intake）. “a and 
b” are high magniﬁcation of “A and B”. The liver of EH was the atypical cells.
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Fig. 6　Inﬂuence on platelet aggregation by the light 
scattering method
The light scattering method revealed that large-sized 
aggregates of EH group had increased as compared 
with the control （P＜0.05）. （each group : n＝5, mean
±SE）
Fig. 4　Blood ALP level
Blood ALP increased in the EH group. Asterisk 
shows significant difference for control （p＜0.05）. 
（each group : n＝5, mean±SE）
Fig. 5　Inﬂuence on blood ﬂuidity
A : Heparin was used for anticoagulant.
B : EDTA was used for anticoagulant.
The blood ﬂuidity of EH group had increased as compared with the control  
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CHANGES IN BLOOD FLUIDITY IN THE EARLY STAGE  
OF HEPATOPATHY
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Department Physiology, Showa University School of Medicine
　Abstract 　　 The present study was designed to examine the inﬂuence of the early stage of hepatop-
athy on blood ﬂuidity.  F344 male rats were fed chow containing 3’-methyl-4-dimethylaminoazobenzene at 
0.06％ （DAB） or regular diet （control）.  These rats were sacriﬁced 16 weeks after for the experiments. 
Histological observation of liver obtained from DAB intake rats showed fatty degeneration and atypical 
cells, indicating that oral administration of DAB for 16 weeks caused the early stages of hepatopathy in 
rats.  We then examined blood ﬂuidity and the levels of platelet aggregation by using a Micro Channel 
array Flow Analyzer and a PA-20, respectively.  The ﬂuidity of the blood obtained from DAB intake rats 
decreased and platelet aggregation increased as compared with those of control.  In the DAB intake 
group, platelet aggregation might have been enhanced by inﬂammatory substances and cytokines in ad-
dition to changes of hepatic metabolic function resulting in a decrease of blood ﬂuidity.  Our results sug-
gest that blood ﬂuidity and platelet aggregation examination may be useful as an index of early stage in 
hepatopathy.
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